The same tendency was found in a study where 197 specimens of FIGO stage I–IV ovarian cancer were evaluated for PD-1+ and PD-L1+ tumour-infiltrating immune cells and prognosis: only the PD-1+ immune cells were associated with better OS results. This evidence concerns the gene CD274 and ovarian carcinoma.